The Burden of Survivorship on Hematological Patients-Long-Term Analysis of Toxicities after Total Body Irradiation and Allogeneic Stem Cell Transplantation.
Michael OertelJonas MartelJan-Henrik MikeschSergiu ScobioalaChristian ReichertsKai KrögerGeorg LenzMatthias StelljesHans Theodor EichPublished in: Cancers (2021)
Total body irradiation is an effective conditioning modality before autologous or allogeneic stem cell transplantation. With the whole body being the radiation target volume, a diverse spectrum of toxicities has been reported. This fact prompted us to investigate the long-term sequelae of this treatment concept in a large patient cohort. Overall, 322 patients with acute leukemia or myelodysplastic syndrome with a minimum follow-up of one year were included (the median follow-up in this study was 68 months). Pulmonary, cardiac, ocular, neurological and renal toxicities were observed in 23.9%, 14.0%, 23.6%, 23.9% and 20.2% of all patients, respectively. The majority of these side effects were grades 1 and 2 (64.9-89.2% of all toxicities in the respective categories). The use of 12 Gray total body irradiation resulted in a significant increase in ocular toxicities (p = 0.013) and severe mucositis (p < 0.001). Renal toxicities were influenced by the age at transplantation (relative risk: 1.06, p < 0.001) and disease entity. In summary, total body irradiation triggers a multifaceted, but manageable, toxicity profile. Except for ocular toxicities and mucositis, a 12 Gray regimen did not lead to an increase in long-term side effects.
Keyphrases
- stem cell transplantation
- high dose
- end stage renal disease
- radiation induced
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- prognostic factors
- bone marrow
- oxidative stress
- young adults
- pulmonary hypertension
- early onset
- stem cells
- replacement therapy
- subarachnoid hemorrhage
- optical coherence tomography
- smoking cessation
- cerebral ischemia